Literature DB >> 11431652

Statistical issues relating to international differences in clinical trials.

J C O'Shea1, D L DeMets.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11431652     DOI: 10.1067/mhj.2001.116275

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  4 in total

1.  AAPS/RAPS/CAPRA collaborative program: exploring the challenges of drug regulation in a global environment: clinical concerns.

Authors:  Marilyn N Martinez; Iain McGilveray
Journal:  AAPS PharmSci       Date:  2003-10-23

Review 2.  'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.

Authors:  Andrea Manca; Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis.

Authors:  Wei-Ching Chang; William K Midodzi; Cynthia M Westerhout; Eric Boersma; Judith Cooper; Elliot S Barnathan; Maarten L Simoons; Lars Wallentin; E Magnus Ohman; Paul W Armstrong
Journal:  J Epidemiol Community Health       Date:  2005-05       Impact factor: 3.710

4.  Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis.

Authors:  Ngianga-Bakwin Kandala; Martin Connock; Amy Grove; Paul Sutcliffe; Syed Mohiuddin; Louise Hartley; Rachel Court; Ewen Cummins; Caroline Gordon; Aileen Clarke
Journal:  BMJ Open       Date:  2013-07-19       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.